Live Breaking News & Updates on மருந்து எச்சரிக்கை
Stay updated with breaking news from மருந்து எச்சரிக்கை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Drug Alert issued for Castlegar SHARE ON: Ankors tested the light pink powder substance and found high concentrations of Fentanyl and Benzodiazepines. “High risk of overdose with prolonged sedation, may not respond to Naloxone, continue to give breaths and seek medical attention,” said Interior Health. Ankors has offered the following tips and guidelines to protect the public: Get your drugs checked Avoid using drugs and alcohol together Don’t use alone Start with a small amount Go slow Call 911 immediately if something doesn’t feel right Give rescue breaths and Naloxone if someone has decreased breathing or other signs of an overdose
A police officer and Police Community Support Officer (Image: Devon & Cornwall Police - issued with a media release - free for use by all LDRS partners) Increased anti-social behaviour, alcohol and drug problems, hate activity and abuse have all been identified as problems in Cornwall as a result of Covid and lockdown. The Safer Cornwall Partnership – which brings together representatives from Cornwall Council, Devon and Cornwall Police, the NHS and probation service – have provided details of new risks that have been highlighted in Cornwall. They were included in a report which went before Cornwall Council’s neighbourhoods overview and scrutiny committee on Thursday.
Brief description of the problem Fairmed Healthcare GmbH has informed us of a discrepancy on the product packaging for the above batches. The discrepancy relates to the incorrect spelling of one of the active pharmaceutical ingredients printed on one side (end flap) of the packs in error. The incorrect end flap states that the active pharmaceutical ingredient is ‘carbiopa’ instead of ‘carbidopa’, (see Annex 1 in the attached document below). The other product details on the pack including the name, strength and pharmaceutical form of the medicine are correct on all other sides of the carton. Advice for healthcare professionals Healthcare professionals are advised to exercise caution when dispensing the product. There is no risk to product quality as a result of this issue, therefore the associated batches are not being recalled at this time.
Brief description of the problem Generics [UK] Limited t/a Mylan have informed us that the Patient Information Leaflet (PIL) within the packs for the products listed above is missing relevant important safety information. The corrected sections of the PIL include the addition of the information listed below. Missing information Section 2 Do not take Perindopril Erbumine: If you are having dialysis or any other type of blood filtration. Depending on the machine that is used, Perindopril Erbumine may not be suitable for you. If you have kidney problems where the blood supply to your kidneys is reduced (renal artery stenosis).